Inclusion completed

A phase I/II , open-label study of nivolumab monotherapy or nivolumab combined with ipilimumab in subjects with advanced or metastatic solid tumors

Cancer type: Solide tumores

Phase: I/II

Principal Investigator: Bono Petri

Country: FI

Keywords: Finland

Status: Inclusion completed

Link to Clinicaltrials.gov: http://clinicaltrials.gov/ct2/show/NCT01928394?term=ca209-032&rank=1